论文部分内容阅读
本文以阐明茜草科为代表的合瓣花植物的植物及其培养细胞产生的环烯醚萜甙的抗促癌活性,对这些植物作为新的医药资源进行评价为实验目的。将茜草科栀子植物为代表的合瓣花植物及其培养细胞产生的环烯醚萜甙分离出来并生成衍生物,研究其对TPA而致的Raji细胞Epstein-Barr病毒早期抗原的抑制活性。将栀子及其类缘植物果实中含有多量的geniposide(2)加水分解,得到的genipin(1)是迄今为止所研究的环烯醚萜甙中活性最强的物质。1与2共存时,在活性上显示相乘作用。genipill(1),在用4-硝基喹啉
This article aims to clarify the anti-cancer activity of iridoids produced by the plants of the Gentiana plant represented by Valerianaceae and their cultured cells, and to evaluate these plants as new medical resources for experimental purposes. The iridoid plants produced by the plant and its cultured cells, represented by Gardenia edulis plants, were isolated and produced derivatives, and their inhibitory activities against TPA-induced Rag cell Epstein-Barr virus early antigens were studied. The genipin (1), which contains a large amount of geniposide (2) in the fruit of gardenia and its genus, is the most active substance in the iridoid studied so far. When 1 and 2 coexist, the multiplication effect is shown on the activity. Genipill(1) with 4-nitroquinoline